Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cyclo Therapeutics

0.7206
+0.0000
Volume:- -
Turnover:126.64K
Market Cap:23.59M
PE:-0.79
High:0.7206
Open:0.7206
Low:0.7206
Close:0.7206
Loading ...

Company Profile

Company Name:
Cyclo Therapeutics
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. The company's lead drug candidate is Trappsol Cyclo, an orphan drug for the treatment of Niemann-Pick Type C disease. It also sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in September 2019. Cyclo Therapeutics, Inc. was founded in 1990 and is based in Gainesville, Florida.